Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Times Interest Earned (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Times Interest Earned for 15 consecutive years, with -$6.45 as the latest value for Q1 2025.

  • Quarterly Times Interest Earned rose 93.35% to -$6.45 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$27.92 through Dec 2025, up 66.0% year-over-year, with the annual reading at -$27.92 for FY2025, 66.0% up from the prior year.
  • Times Interest Earned for Q1 2025 was -$6.45 at Plus Therapeutics, up from -$68.42 in the prior quarter.
  • The five-year high for Times Interest Earned was -$6.45 in Q1 2025, with the low at -$136.93 in Q2 2024.
  • Average Times Interest Earned over 5 years is -$43.03, with a median of -$31.48 recorded in 2022.
  • The sharpest move saw Times Interest Earned crashed 929.24% in 2024, then surged 93.35% in 2025.
  • Over 5 years, Times Interest Earned stood at -$15.08 in 2021, then plummeted by 232.84% to -$50.2 in 2022, then dropped by 23.96% to -$62.23 in 2023, then decreased by 9.96% to -$68.42 in 2024, then surged by 90.57% to -$6.45 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$6.45, -$68.42, and -$62.28 for Q1 2025, Q4 2024, and Q3 2024 respectively.